Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
暂无分享,去创建一个
Anna L. Brown | J. Bryant | D. Wickerham | N. Wolmark | H. Bear | E. Mamounas | B. Fisher | R. Margolese | A. Brown | A. Robidoux | A. Cruz | E. Fisher | A. DeCillis | J. Hoehn | A. Lees | N. Dimitrov | M. Begovic | E. Fisher | N. Wolmark | Edwin R. Fisher | Harry D. Bear | Richard G. Margolese | Bernard Fisher | John Bryant | Norman Wolmark | Eleftherios P. Mamounas | Donald L. Wickerham | Mirsada Begovic | Arthur DeCillis | André Robidoux | James L. Hoehn | E. Mamounas
[1] H. Skipper,et al. Kinetics of mammary tumor cell growth and implications for therapy , 1971, Cancer.
[2] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[3] N Gunduz,et al. Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.
[4] G. Lesnick,et al. Chemotherapy before and after mastectomy in stage III breast cancer. , 1982, Archives of surgery.
[5] N Gunduz,et al. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.
[6] J. Butler,et al. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer , 1983, Journal of surgical oncology.
[7] C. Redmond,et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.
[8] N Gunduz,et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. , 1989, Cancer research.
[9] B. Fisher,et al. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. , 1989, Cancer research.
[10] L. Mauriac,et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] B. Asselain,et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.
[12] T. Powles,et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] E. Mamounas,et al. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] B. Asselain,et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. , 1995, European journal of cancer.
[15] D. Wickerham,et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] B Fisher,et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. , 1997, Journal of the National Cancer Institute.